Weaponizing Neoantigens to Create Truly
Personalized Cancer Vaccines & Cellular Immunotherapies
The 4th annual NeoAg Summit is returning to Boston this November to provide your team with one all-inclusive forum to successfully target tumor-specific neoantigens and bring to market personalized cancer vaccines and cellular therapies.
With record numbers of neoantigen-targeted cancer immunotherapies entering the clinic, the time is now to join your community to gain a clear understanding of the leading prediction platforms and gain a comprehensive overview of the clinical landscape.
Join the likes of Neon Therapeutics, Gritstone Oncology, Genocea & many more to;
- Advance neoantigen prediction to identify reliable targets
- Interrogate delivery platforms to maximize immunogenicity
- Reduce needle to needle time and scale manufacture
… to improve the commercial potential of personalized therapies.
Expert Speakers Include
Stephen Schoenberger
Center Head, Professor, Division of Developmental Immunology
La Jolla Institute for Allergy & Immunology
What Can You Expect?
Hear What Our Attendees Say
"Great opportunity to learn how to develop and accelerate neoantigen related products not only from speakers but also participants and partners."
BrightPath Biotherapeutics
"The Neoantigen Summit is the focal point for updates in the cancer neoantigen vaccine field and should be attended by everybody with a keen interest in the field."
Vaccibody
Proud To Partner With
Industry Development Partner:
Expertise Partner:
Industry Partner:
Program Partner:
Hosting Partner:
Exhibitor Partner:
